Filing Details
- Accession Number:
- 0001127602-11-004641
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-02-09 12:00:00
- Reporting Period:
- 2011-02-07
- Filing Date:
- 2011-02-09
- Accepted Time:
- 2011-02-09 16:35:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1022079 | Quest Diagnostics Inc | DGX | Services-Medical Laboratories (8071) | 161387862 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1018538 | R Gail Wilensky | C/O Quest Diagnostics Incorporated 3 Giralda Farms Madison NJ 07940 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-02-07 | 20,000 | $29.53 | 35,226 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-02-07 | 10,000 | $58.55 | 25,226 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2011-02-07 | 5,000 | $58.58 | 20,226 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2011-02-07 | 5,000 | $58.60 | 15,226 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | Disposition | 2011-02-07 | 20,000 | $0.00 | 20,000 | $29.53 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2011-05-08 | No | 4 | M | Direct |
Footnotes
- The options vested in three annual installments beginning with the first on May 8, 2002, the second on May 8, 2003 and the final on May 8, 2004.
- This transaction was executed in multiple trades at prices ranging from $58.54 to $58.58. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $58.5715 to $58.59. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $58.5951 to $58.60. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
